Literature DB >> 7631607

Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death.

E G Daoud1, M Niebauer, W H Kou, K C Man, L Horwood, F Morady, S A Strickberger.   

Abstract

Coronary revascularization has been suggested as sole therapy for secondary prevention of sudden cardiac arrest associated with ischemia. The use of implantable defibrillators (ICD) in combination with coronary revascularization for this patient population is unclear. Among 412 consecutive patients receiving an ICD, 23 (6%) were identified as sudden cardiac arrest survivors who were noninducible with programmed stimulation and had unstable angina or ischemia on a functional study; they underwent successful coronary revascularization. During a follow-up of 34 +/- 18 months, 10 (43%) of the 23 patients received ICD shocks (8 +/- 8 per patient, range 1 to 22 shocks), and nine of the 10 patients had syncope/presyncope associated with at least one ICD discharge. Patients with ICD discharges were compared with those without ICD discharges, and no clinical characteristics were statistically different between the two groups. In conclusion, revascularization alone may be inadequate therapy for survivors of sudden cardiac arrest associated with ischemia who are noninducible with programmed stimulation, and clinical variables cannot predict which patients are likely to have recurrent malignant ventricular arrhythmias.

Entities:  

Mesh:

Year:  1995        PMID: 7631607     DOI: 10.1016/0002-8703(95)90440-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

Review 1.  Clinical review: beyond immediate survival from resuscitation-long-term outcome considerations after cardiac arrest.

Authors:  Dilshan Arawwawala; Stephen J Brett
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

2.  The effect of revascularization on mortality and risk of ventricular arrhythmia in patients with ischemic cardiomyopathy.

Authors:  Ahmad Alkharaza; Mousa Al-Harbi; Ihab El-Sokkari; Steve Doucette; Ciorsti MacIntyre; Christopher Gray; Amir Abdelwahab; John L Sapp; Martin Gardner; Ratika Parkash
Journal:  BMC Cardiovasc Disord       Date:  2020-10-21       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.